Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
481.8 GBX | +0.46% | +1.73% | -1.07% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.84B 2.34B | Sales 2025 * | 1.98B 2.52B | Capitalization | 1.51B 1.91B |
---|---|---|---|---|---|
Net income 2024 * | 64M 81.41M | Net income 2025 * | 91M 116M | EV / Sales 2024 * | 0.82 x |
Net cash position 2024 * | 3.47M 4.41M | Net cash position 2025 * | 8.03M 10.21M | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
16
x | Employees | 7,859 |
Yield 2024 * |
5% | Yield 2025 * |
5.94% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +1.27% | ||
1 week | +2.62% | ||
Current month | +8.92% | ||
1 month | +9.95% | ||
3 months | +9.36% | ||
6 months | +9.07% | ||
Current year | -0.21% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 22-12-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Kaye Maguire
LAW | General Counsel | - | 18-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 17-08-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Karen Geary
BRD | Director/Board Member | - | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 481.8 | +0.46% | 273 186 |
24-05-20 | 479.6 | +1.10% | 219,004 |
24-05-17 | 474.4 | +0.08% | 191,515 |
24-05-16 | 474 | -1.29% | 137,686 |
24-05-15 | 480.2 | +1.39% | 235,110 |
Delayed Quote London S.E., May 21, 2024 at 07:58 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.21% | 1.91B | |
+10.68% | 3.43B | |
+18.96% | 711M |
- Stock Market
- Equities
- MPI Stock